http://45982538.hs-sites.com/blog en Tue, 21 Jul 2026 19:56:11 GMT 2026-07-21T19:56:11Z en http://45982538.hs-sites.com/blog/glass-box-ai-a-higher-standard-for-what-medical-imaging-can-tell-us <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/glass-box-ai-a-higher-standard-for-what-medical-imaging-can-tell-us" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/Screenshot-2024-06-01-at-14.53.04-1.png" alt="Glass-Box AI: A Higher Standard for What Medical Imaging Can Tell Us" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/glass-box-ai-a-higher-standard-for-what-medical-imaging-can-tell-us" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/Screenshot-2024-06-01-at-14.53.04-1.png" alt="Glass-Box AI: A Higher Standard for What Medical Imaging Can Tell Us" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fglass-box-ai-a-higher-standard-for-what-medical-imaging-can-tell-us&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> News Article Fri, 29 May 2026 04:00:00 GMT http://45982538.hs-sites.com/blog/glass-box-ai-a-higher-standard-for-what-medical-imaging-can-tell-us 2026-05-29T04:00:00Z admin http://45982538.hs-sites.com/blog/baseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/baseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/%5BPosted%5D%20ASCO%202026%20Carousel%20(1).png" alt="Baseline CT-derived QVT score as predictor of bevacizumab benefit in advanced non-squamous NSCLC" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/baseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/%5BPosted%5D%20ASCO%202026%20Carousel%20(1).png" alt="Baseline CT-derived QVT score as predictor of bevacizumab benefit in advanced non-squamous NSCLC" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fbaseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Lung CT MRI QVT Wed, 27 May 2026 15:30:00 GMT http://45982538.hs-sites.com/blog/baseline-ct-derived-qvt-score-as-predictor-of-bevacizumab-benefit-in-advanced-non-squamous-nsclc 2026-05-27T15:30:00Z admin http://45982538.hs-sites.com/blog/ai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-he-images-to-predict-immunotherapy-benefit-over-chemotherapy-in-nsclc-blinded-validation-in-1780599181946 <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/ai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-he-images-to-predict-immunotherapy-benefit-over-chemotherapy-in-nsclc-blinded-validation-in-1780599181946" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/ASCO%20logo.webp" alt="AI-derived CD8+ cytotoxic T-cell immune signatures from baseline H&amp;E images to predict immunotherapy benefit over chemotherapy in NSCLC: Blinded validation in CheckMate-227 (CM227)" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/ai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-he-images-to-predict-immunotherapy-benefit-over-chemotherapy-in-nsclc-blinded-validation-in-1780599181946" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/ASCO%20logo.webp" alt="AI-derived CD8+ cytotoxic T-cell immune signatures from baseline H&amp;E images to predict immunotherapy benefit over chemotherapy in NSCLC: Blinded validation in CheckMate-227 (CM227)" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-he-images-to-predict-immunotherapy-benefit-over-chemotherapy-in-nsclc-blinded-validation-in-1780599181946&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Lung Immunotherapy Wed, 27 May 2026 11:00:00 GMT http://45982538.hs-sites.com/blog/ai-derived-cd8-cytotoxic-t-cell-immune-signatures-from-baseline-he-images-to-predict-immunotherapy-benefit-over-chemotherapy-in-nsclc-blinded-validation-in-1780599181946 2026-05-27T11:00:00Z admin http://45982538.hs-sites.com/blog/noninvasive-imaging-biomarkers-for-survival-risk-stratification-with-tarlatamab-in-es-sclc <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/noninvasive-imaging-biomarkers-for-survival-risk-stratification-with-tarlatamab-in-es-sclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/ASCO%20logo.webp" alt="Noninvasive imaging biomarkers for survival risk stratification with tarlatamab in ES-SCLC" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/noninvasive-imaging-biomarkers-for-survival-risk-stratification-with-tarlatamab-in-es-sclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/ASCO%20logo.webp" alt="Noninvasive imaging biomarkers for survival risk stratification with tarlatamab in ES-SCLC" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fnoninvasive-imaging-biomarkers-for-survival-risk-stratification-with-tarlatamab-in-es-sclc&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Lung Wed, 27 May 2026 11:00:00 GMT http://45982538.hs-sites.com/blog/noninvasive-imaging-biomarkers-for-survival-risk-stratification-with-tarlatamab-in-es-sclc 2026-05-27T11:00:00Z admin http://45982538.hs-sites.com/blog/qvt-subscore-an-interpretable-radiomic-panel-of-tumor-vascularity-reveals-treatment-specific-mechanisms-of-action-moa-in-nsclc <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/qvt-subscore-an-interpretable-radiomic-panel-of-tumor-vascularity-reveals-treatment-specific-mechanisms-of-action-moa-in-nsclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/download.jpeg" alt="QVT Subscore: An interpretable radiomic panel of tumor vascularity reveals treatment-specific mechanisms-of-action (MoA) in NSCLC" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/qvt-subscore-an-interpretable-radiomic-panel-of-tumor-vascularity-reveals-treatment-specific-mechanisms-of-action-moa-in-nsclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/download.jpeg" alt="QVT Subscore: An interpretable radiomic panel of tumor vascularity reveals treatment-specific mechanisms-of-action (MoA) in NSCLC" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fqvt-subscore-an-interpretable-radiomic-panel-of-tumor-vascularity-reveals-treatment-specific-mechanisms-of-action-moa-in-nsclc&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Lung Wed, 01 Apr 2026 12:00:00 GMT http://45982538.hs-sites.com/blog/qvt-subscore-an-interpretable-radiomic-panel-of-tumor-vascularity-reveals-treatment-specific-mechanisms-of-action-moa-in-nsclc 2026-04-01T12:00:00Z admin http://45982538.hs-sites.com/blog/computationally-derived-spatial-immune-signature-identifies-trastuzumab-responders-in-her2-breast-cancer-nsabp-b-41-clinical-trial-validation <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/computationally-derived-spatial-immune-signature-identifies-trastuzumab-responders-in-her2-breast-cancer-nsabp-b-41-clinical-trial-validation" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/AACR%20logo.jpeg" alt="Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B-41 Clinical Trial Validation" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/computationally-derived-spatial-immune-signature-identifies-trastuzumab-responders-in-her2-breast-cancer-nsabp-b-41-clinical-trial-validation" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/AACR%20logo.jpeg" alt="Computationally Derived Spatial Immune Signature Identifies Trastuzumab Responders in HER2+ Breast Cancer: NSABP B-41 Clinical Trial Validation" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fcomputationally-derived-spatial-immune-signature-identifies-trastuzumab-responders-in-her2-breast-cancer-nsabp-b-41-clinical-trial-validation&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Breast Tue, 31 Mar 2026 11:00:00 GMT http://45982538.hs-sites.com/blog/computationally-derived-spatial-immune-signature-identifies-trastuzumab-responders-in-her2-breast-cancer-nsabp-b-41-clinical-trial-validation 2026-03-31T11:00:00Z admin http://45982538.hs-sites.com/blog/computational-pathology-features-of-immune-architecture-predict-clinically-relevant-outcomes-in-small-cell-lung-cancer-sclc <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/computational-pathology-features-of-immune-architecture-predict-clinically-relevant-outcomes-in-small-cell-lung-cancer-sclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/npj-precision-oncology_potw.webp" alt="Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC)" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <div class="hs-featured-image-wrapper"> <a href="http://45982538.hs-sites.com/blog/computational-pathology-features-of-immune-architecture-predict-clinically-relevant-outcomes-in-small-cell-lung-cancer-sclc" title="" class="hs-featured-image-link"> <img src="https://45982538.hs-sites.com/hubfs/npj-precision-oncology_potw.webp" alt="Computational pathology features of immune architecture predict clinically relevant outcomes in small-cell lung cancer (SCLC)" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fcomputational-pathology-features-of-immune-architecture-predict-clinically-relevant-outcomes-in-small-cell-lung-cancer-sclc&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Lung Tue, 17 Mar 2026 11:00:00 GMT http://45982538.hs-sites.com/blog/computational-pathology-features-of-immune-architecture-predict-clinically-relevant-outcomes-in-small-cell-lung-cancer-sclc 2026-03-17T11:00:00Z admin http://45982538.hs-sites.com/blog/mutrim-a-multiscale-deep-learning-model-integrating-longitudinal-radiomics-and-pathomic-features-for-predicting-recurrence-and-adjuvant-radiation-benefit-in-1780602294005 <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fmutrim-a-multiscale-deep-learning-model-integrating-longitudinal-radiomics-and-pathomic-features-for-predicting-recurrence-and-adjuvant-radiation-benefit-in-1780602294005&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> CT Breast MRI Thu, 12 Mar 2026 11:00:00 GMT http://45982538.hs-sites.com/blog/mutrim-a-multiscale-deep-learning-model-integrating-longitudinal-radiomics-and-pathomic-features-for-predicting-recurrence-and-adjuvant-radiation-benefit-in-1780602294005 2026-03-12T11:00:00Z admin http://45982538.hs-sites.com/blog/qvt-score-a-radiomic-biomarker-of-vascular-complexity-enables-prognostication-and-monitoring-of-nsclc-immunotherapy <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fqvt-score-a-radiomic-biomarker-of-vascular-complexity-enables-prognostication-and-monitoring-of-nsclc-immunotherapy&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Lung Fri, 20 Feb 2026 12:00:00 GMT http://45982538.hs-sites.com/blog/qvt-score-a-radiomic-biomarker-of-vascular-complexity-enables-prognostication-and-monitoring-of-nsclc-immunotherapy 2026-02-20T12:00:00Z admin http://45982538.hs-sites.com/blog/leveraging-ai-enabled-tumor-assessment-tools-on-radiological-images-to-evaluate-treatment-effect-and-support-clinical-trial-endpoints-in-solid-tumors <img src="https://track.hubspot.com/__ptq.gif?a=45982538&amp;k=14&amp;r=http%3A%2F%2F45982538.hs-sites.com%2Fblog%2Fleveraging-ai-enabled-tumor-assessment-tools-on-radiological-images-to-evaluate-treatment-effect-and-support-clinical-trial-endpoints-in-solid-tumors&amp;bu=http%253A%252F%252F45982538.hs-sites.com%252Fblog&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> RECIST Tue, 27 Jan 2026 12:00:00 GMT http://45982538.hs-sites.com/blog/leveraging-ai-enabled-tumor-assessment-tools-on-radiological-images-to-evaluate-treatment-effect-and-support-clinical-trial-endpoints-in-solid-tumors 2026-01-27T12:00:00Z admin